Literature DB >> 1790745

Clinical analysis of Fuchs' heterochromic cyclitis.

E La Hey1, G S Baarsma, J De Vries, A Kijlstra.   

Abstract

Fuchs' heterochromic cyclitis (FHC) is an important diagnosis to make. Not only for the patient, because incorrect diagnosis may lead to unnecessary therapy and the failure to detect secondary glaucoma, but also for the comparison of studies on the etiology of FHC, which is still unknown. No clinical criteria for establishing the diagnosis of FHC have been internationally accepted yet. By means of clinical analyses of FHC patients in different parts of the world, predominant clinical features may be distinguished and combined to form (internationally accepted) diagnostic criteria. We report a clinical analysis of 51 FHC patients in the Netherlands. Acute symptoms (severe redness, pain or photophobia) were never (100%) encountered. Characteristic keratic precipitates (88%) and/or minimal aqueous cells and flare (60%) and/or vitreous opacities (84%) were major signs, indicating a chronic inflammatory activity, in which no synechiae (100%) were present. Heterochromia (82%) was not a constant sign, but iris stromal atrophy, which causes the heterochromia, was always present (100%). Cataract was present in 82% as a result of the chronic iridocyclitis. Secondary glaucoma was present in 22%. Based on the predominant clinical findings obtained from this analysis of FHC patients, and on data in the literature, we propose clinical diagnostic criteria for FHC. Future studies, also including other uveitis groups, are necessary to confirm these diagnostic criteria.

Entities:  

Mesh:

Year:  1991        PMID: 1790745     DOI: 10.1007/bf00165685

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  11 in total

1.  Signs and symptoms of uveitis. I. Anterior uveitis.

Authors:  M J HOGAN; S J KIMURA; P THYGESON
Journal:  Am J Ophthalmol       Date:  1959-05       Impact factor: 5.258

2.  Fuchs' syndrome of heterochromic cyclitis.

Authors:  S J KIMURA; M J HOGAN; P THYGESON
Journal:  AMA Arch Ophthalmol       Date:  1955-08

3.  Extracapsular cataract extraction with posterior chamber lens implantation in Fuch's heterochromic cyclitis.

Authors:  G S Baarsma; J de Vries; C D Hammudoglu
Journal:  Br J Ophthalmol       Date:  1991-05       Impact factor: 4.638

4.  Lens Opacities Classification System.

Authors:  L T Chylack; M C Leske; R Sperduto; P Khu; D McCarthy
Journal:  Arch Ophthalmol       Date:  1988-03

5.  Fuchs's heterochromic cyclitis: A critical review of the literature. I. Clinical characteristics of the syndrome.

Authors:  I E Loewenfeld; H S Thompson
Journal:  Surv Ophthalmol       Date:  1973 May-Jun       Impact factor: 6.048

6.  Fuchs' heterochromic iridocyclitis in blacks.

Authors:  B R Tabbut; H H Tessler; D Williams
Journal:  Arch Ophthalmol       Date:  1988-12

7.  Chorioretinal scars in Fuchs' heterochromic iridocyclitis.

Authors:  R C Arffa; T F Schlaegel
Journal:  Arch Ophthalmol       Date:  1984-08

8.  Clinical features and prognosis in Fuchs' uveitis syndrome.

Authors:  T J Liesegang
Journal:  Arch Ophthalmol       Date:  1982-10

Review 9.  Doyne lecture. Heterochromic iridocyclitis.

Authors:  G R O'Connor
Journal:  Trans Ophthalmol Soc U K       Date:  1985

10.  Fuchs' heterochromic cyclitis and ocular toxoplasmosis.

Authors:  M Toledo de Abreu; R Belfort; P S Hirata
Journal:  Am J Ophthalmol       Date:  1982-06       Impact factor: 5.258

View more
  21 in total

1.  Fuchs' heterochromic iridocyclitis associated with ocular toxocariasis.

Authors:  Noriyasu Hashida; Nobuyuki Ohguro; Haruhiko Maruyama
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

Review 2.  [Fuchs uveitis].

Authors:  L Daas; B Seitz; U Pleyer
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

3.  Analysis of iris structure and iridocorneal angle parameters with anterior segment optical coherence tomography in Fuchs' uveitis syndrome.

Authors:  Berna Basarir; Cigdem Altan; Eylem Yaman Pinarci; Ugur Celik; Banu Satana; Ahmet Demirok
Journal:  Int Ophthalmol       Date:  2013-01-01       Impact factor: 2.031

4.  Evaluation of radial peripapillary capillary density in patients with Fuchs uveitis syndrome.

Authors:  Yasin Sakir Goker; Pinar Cakar Ozdal; Yasemin Ozdamar Erol; Hasan Kızıltoprak; Mustafa Salih Karatepe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-22       Impact factor: 3.117

5.  Fuch's heterochromic cyclitis and HLA histocompatibility antigens.

Authors:  G Muñoz; M P López-Corell; J F Taboada; E Ferrer; M Díaz-Llopis
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

6.  Contralateral active ocular toxoplasmosis in Fuchs' heterochromic cyclitis.

Authors:  E La Hey; G S Baarsma
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

7.  Full-thickness choroidal thinning as a feature of Fuchs Uveitis Syndrome: quantitative evaluation of the choroid by Enhanced Depth Imaging Optical Coherence Tomography in a cohort of consecutive patients.

Authors:  Alessio Cerquaglia; Barbara Iaccheri; Tito Fiore; Marco Lupidi; Giovanni Torroni; Daniela Fruttini; Claudia Giacalone; Carlo Cagini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-02       Impact factor: 3.117

8.  Fluorescein angiographic findings and clinical features in Fuchs' uveitis.

Authors:  Nadia Bouchenaki; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2010-04-18       Impact factor: 2.031

9.  Incidence and changing patterns of uveitis in Central Tokyo.

Authors:  Takafumi Suzuki; Toshikatsu Kaburaki; Rie Tanaka; Shintaro Shirahama; Keiko Komae; Hisae Nakahara; Mitsuko Takamoto; Hidetoshi Kawashima; Makoto Aihara
Journal:  Int Ophthalmol       Date:  2021-05-28       Impact factor: 2.031

10.  Fuchs' Uveitis: Failure to Associate Vitritis and Disc Hyperfluorescence with the Disease is the Major Factor for Misdiagnosis and Diagnostic Delay.

Authors:  Nadia Bouchenaki; Carl P Herbort
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.